Adicet Bio第二季度每股收益$（0.34）错过$（0.30）估计

Adicet Bio (NASDAQ: ACET) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 12.58 percent. This is a 3.03 percent decrease over losses of $(0.33) per share from the same period last year.